Edition:
United States

Medgenics Inc (MDGN.A)

MDGN.A on American Stock Exchange

5.98USD
22 Jul 2016
Change (% chg)

$0.25 (+4.36%)
Prev Close
$5.73
Open
$5.74
Day's High
$5.99
Day's Low
$5.73
Volume
6,796
Avg. Vol
27,073
52-wk High
$10.25
52-wk Low
$3.13

MDGN.A

Chart for MDGN.A

About

Medgenics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on genomic medicine. The Company is engaged in the development of NFC-1. NFC-1 is a non-stimulant metabotropic glutamate receptor (mGluR) neuromodulator for the treatment of mGluR network mutation positive Attention Deficit Hyperactivity Disorder... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $220.37
Shares Outstanding(Mil.): 36.85
Dividend: --
Yield (%): --

Financials

  MDGN.A Industry Sector
P/E (TTM): -- 39.80 37.05
EPS (TTM): -1.44 -- --
ROI: -119.09 -5.86 14.35
ROE: -122.78 -4.70 15.56

BRIEF-Adage Capital Partners reports 5.70 pct passive stake in Medgenics

* Adage Capital Partners reports 5.70 pct passive stake in Medgenics as of June 21 - sec filing Source text: http://1.usa.gov/29fLbrz Further company coverage: (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)

Jun 30 2016

BRIEF-Medgenics enters collaboration with Kyowa Hakko Kirin

* Entered collaboration with Kyowa Hakko Kirin Co Ltd for development and commercialization of Kyowa Hakko's anti-light monoclonal antibody

Jun 06 2016

BRIEF-Medgenics Q1 loss per share $0.34

* Reports First Quarter 2016 Financial Results And Nfc-1 program update

May 10 2016

BRIEF-Medgenics hires Michael Diem as senior vice president of business and corporate development

* Medgenics hires michael diem as senior vice president of business and corporate development Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 03 2016

BRIEF-Medgenics says hired Eric Phillips as vice president of regulatory affairs

* Medgenics hires Eric Phillips, MPH, SCD as vice president of Regulatory Affairs Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Apr 20 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.